Expert says ‘recent weaknesses in the Hong Kong dollar against other regional currencies’ could help to sustain growth in ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

Major stock markets diverged and the dollar slid Wednesday as euphoria over easing US-China trade tensions petered out.

UBS says wealthy Asian investors are moving away from the US dollar into gold, crypto and Chinese assets, driven by ...

Asian shares are mostly higher as a cautious sense of relief spreads through regional markets after the U.S. and China agreed ...

In a move to intensify pressure on Tehran, the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC) ...

U.S. stocks are holding relatively steady following a report that showed inflation unexpectedly slowed across the country ...

Shares have logged modest gains in most world markets as the initial euphoria over the 90-day truce in the trade war between ...

The number of shipments entering the U.S. through the tax-free channel exploded in recent years with more than 90% of all ...